Massachusetts-based brain implant company Axoft raised a $55M Series A and says it tested its device in a Shanghai patient, with plans for more trials in China — A US company has tested a brain implant in a Chinese patient in Shanghai, a rare sign of cooperation as the two countries compete …
Posted from: this blog via Microsoft Power Automate.
